Correlation Between Conduit Pharmaceuticals and OKYO Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and OKYO Pharma Ltd, you can compare the effects of market volatilities on Conduit Pharmaceuticals and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and OKYO Pharma.

Diversification Opportunities for Conduit Pharmaceuticals and OKYO Pharma

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Conduit and OKYO is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and OKYO Pharma go up and down completely randomly.

Pair Corralation between Conduit Pharmaceuticals and OKYO Pharma

Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 6.02 times more return on investment than OKYO Pharma. However, Conduit Pharmaceuticals is 6.02 times more volatile than OKYO Pharma Ltd. It trades about 0.12 of its potential returns per unit of risk. OKYO Pharma Ltd is currently generating about 0.02 per unit of risk. If you would invest  1.00  in Conduit Pharmaceuticals on September 6, 2024 and sell it today you would earn a total of  0.08  from holding Conduit Pharmaceuticals or generate 8.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy52.38%
ValuesDaily Returns

Conduit Pharmaceuticals  vs.  OKYO Pharma Ltd

 Performance 
       Timeline  
Conduit Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
OKYO Pharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in OKYO Pharma Ltd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, OKYO Pharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Conduit Pharmaceuticals and OKYO Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Conduit Pharmaceuticals and OKYO Pharma

The main advantage of trading using opposite Conduit Pharmaceuticals and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.
The idea behind Conduit Pharmaceuticals and OKYO Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments